Core Viewpoint - The rapid development of the biopharmaceutical industry has led to increased emphasis on downstream purification technologies, making separation and purification a key focus in biopharmaceutical R&D and production [2] Industry Summary - The biopharmaceutical industry is experiencing significant growth, with increased investment in R&D and a faster pace of new product launches, resulting in heightened market competition [2] - There is a pressing demand for high-performance, stable, and reasonably priced domestic separation and purification materials due to the cost and supply pressures faced by biopharmaceutical manufacturers [2] Company Summary - The company has evolved into a leading supplier of domestic chromatography fillers and chromatography media, with a comprehensive range of products and a high market share, thanks to over a decade of cross-disciplinary R&D innovation and product accumulation [2] - The company offers a full series of self-innovated products, including polymer reverse phase, ion exchange, hydrophobic chromatography, and silica gel reverse phase, and has established a wealth of application cases and significant sales revenue in the insulin and peptide drug application areas [2]